Found: 13
Select item for more details and to access through your institution.
Safety, Tolerability, and Pharmacokinetics of Voriconazole for Injection in Two Preparations in Chinese Healthy Adult Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 4, p. 404, doi. 10.1002/cpdd.1370
- By:
- Publication type:
- Article
Population Pharmacokinetic and Pharmacodynamic Modeling of Romiplostim Biosimilar GP40141 and Reference Product in Healthy Volunteers to Evaluate Biosimilarity.
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 4, p. 419, doi. 10.1002/cpdd.1367
- By:
- Publication type:
- Article
Cardiovascular Evaluation of Etrasimod, a Selective Sphingosine 1‐phosphate Receptor Modulator, in Healthy Adults: Results of a Randomized, Thorough QT/QTc Study.
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 4, p. 326, doi. 10.1002/cpdd.1388
- By:
- Publication type:
- Article
Physiologically Based Pharmacokinetic Absorption Model for Pexidartinib to Evaluate the Impact of Meal Contents and Intake Timing on Drug Exposure.
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 4, p. 440, doi. 10.1002/cpdd.1385
- By:
- Publication type:
- Article
Pharmacokinetics and Pharmacodynamics of Etripamil, an Intranasally Administered, Fast‐Acting, Nondihydropyridine Calcium Channel Blocker.
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 4, p. 367, doi. 10.1002/cpdd.1383
- By:
- Publication type:
- Article
Pharmacokinetics, Bioequivalence, and Safety Evaluation of Two Oral Formulations of Calcium Dobesilate Capsules in Healthy Chinese Volunteers Under Fasting and Fed Conditions.
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 4, p. 360, doi. 10.1002/cpdd.1376
- By:
- Publication type:
- Article
Results from a Phase 1 Study Assessing the Pharmacokinetics of the Aldosterone Synthase Inhibitor Baxdrostat in Participants with Varying Degrees of Renal Function.
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 4, p. 410, doi. 10.1002/cpdd.1371
- By:
- Publication type:
- Article
Reduced Plasma Levodopa Fluctuations with More Frequent Administration of a Novel Carbidopa/Levodopa Functionally Scored Tablet.
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 4, p. 380, doi. 10.1002/cpdd.1360
- By:
- Publication type:
- Article
Mass Balance and Metabolite Profile after Single and Multiple Oral Doses of Pritelivir in Healthy Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 4, p. 389, doi. 10.1002/cpdd.1358
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 4, p. 321, doi. 10.1002/cpdd.1117
- Publication type:
- Article
Safety, Tolerability, and Pharmacokinetics of a Novel Oral Phosphodiesterase 4 Inhibitor, ME3183: First‐in‐Human Phase 1 Study.
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 4, p. 341, doi. 10.1002/cpdd.1351
- By:
- Publication type:
- Article
A Randomized, Single‐Dose, Parallel‐Controlled Phase 1 Clinical Comparison of an Omalizumab Biosimilar Candidate with Reference Omalizumab in Healthy Chinese Male Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 4, p. 349, doi. 10.1002/cpdd.1350
- By:
- Publication type:
- Article
Bioequivalence of 240 mg Apalutamide Tablets and Preparation in Aqueous Food Vehicles for Alternative Administration.
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 4, p. 432, doi. 10.1002/cpdd.1346
- By:
- Publication type:
- Article